No new drug approvals or safety communications for this desk today. What did land is guidance, and it is the more consequential kind.
The EAU, with EANM, ESTRO, ESUR, ISUP and SIOG, has published Part I of the 2026 prostate cancer guideline update, covering screening, diagnosis and local treatment with curative intent. A separate 2026 summary updates the guidelines on urological infections.
These are the documents that decide day-to-day practice far more than any single trial does — when to biopsy, how to use MRI before biopsy, who is suitable for active surveillance, and which antibiotic for which urinary infection in an era where resistance has made that a moving target. Both were captured by the sweep as journal publications rather than as regulatory actions, which is why they appear here rather than as an alert.
For Indian practice the infections update is likely the more immediately useful of the two. Empirical treatment of complicated urinary infection is where local resistance patterns diverge most sharply from European ones, and a guideline is a starting point to be read against your own antibiogram rather than adopted.
- Read Part I of the prostate guideline for the screening, diagnosis and curative-treatment sections specifically.
- Check the infections update against your local antibiogram before changing empirical therapy.
- No new drug approvals or recalls affecting urology in today's sweep.
- Guideline updates arrive here as journal articles; they are not flagged as regulatory alerts.
The statistics, in plain English
A guideline carries no effect size of its own; it summarises evidence and grades the strength of each recommendation. The two things to look for when reading one are the strength of recommendation and the certainty of evidence behind it, which are separate and often diverge — a strong recommendation can rest on low-certainty evidence when the alternative is worse. Neither is reproduced in an executive summary, so the full document is where the reasoning lives.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for urology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free